Snapper H et al
As Medicare coverage expansions in 2025 and 2026 extend GLP-1 drugs to millions of older Americans for the first time, researchers and clinicians are urging a different approach for this age group: more careful baseline assessment, slower dosing, higher protein targets, and proactive monitoring for muscle loss, malnutrition, and bone density decline
A plateau is an opportunity to take a breath and re-evaluate your approach
Here is exactly what needs to be in the chart for each code type: When to Send a Physician Query Send a formal query when: High HbA1c or diabetes medications appear on record but no formal diabetes diagnosis is documented A specialist note mentions a complication but the treating physician hasnt connected it to the diabetes The type of diabetes is ambiguous (young thin patient on insulin with no Type 2 risk factors) A drug known to cause diabetes is on the medication list but no causal connection has been drawn CKD is documented but the stage is not specified Retinopathy is documented but the eye is not specified Queries must be objective
While we don't directly bill insurance, we can provide you with the necessary documentation to seek reimbursement from your provider if your plan covers it
The tirzepatide dosage calculator helps researchers plan their supply needs based on their specific protocol duration and dose escalation schedule
